Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 22;4(6):e70059.
doi: 10.1002/jex2.70059. eCollection 2025 Jun.

Detection and Isolation of Tissue-Specific Extracellular Vesicles From the Blood

Affiliations
Review

Detection and Isolation of Tissue-Specific Extracellular Vesicles From the Blood

Lauren Newman et al. J Extracell Biol. .

Abstract

Extracellular vesicles (EVs) are nanosized, membrane-bound particles released by virtually all cell types, serving as messengers within tissues and across organs via the bloodstream. EVs encapsulate diverse molecular cargo that reflects the phenotypic state of their originating cells, making them promising candidates for liquid biopsy applications. However, the heterogeneity of circulating EVs, comprising particles from various cell types and non-vesicular entities like lipoproteins, poses significant challenges for isolating tissue-specific EV populations. This review examines current methodologies for detecting and isolating tissue-specific EVs from blood, focusing on immunoaffinity capture (IAC) strategies that leverage surface marker expression for specificity. Key considerations, including the selection and validation of markers, are discussed alongside advances in EV subtyping and isolation protocols. Challenges such as marker cross-reactivity, EV biogenesis and transport dynamics are highlighted to underscore the complexity of achieving clinical utility. By providing an overview of validated tissue-specific markers and isolation techniques, this review aims to facilitate the development of EV-based biomarkers with enhanced specificity and sensitivity, enabling minimally invasive monitoring of organ function and disease.

Keywords: EV subtypes; cell origin; extracellular vesicles; immunoaffinity isolation; organ‐derived; tissue‐specific.

PubMed Disclaimer

Conflict of interest statement

Andrew Rowland and Lauren Newman are recipients of research funding from Pfizer Inc., AstraZeneca and Boehringer Ingelheim for work outside of the scope of this project. The other authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Circulating extracellular vesicles are derived from multiple origins. EVs from solid tissues represent a minor fraction among contaminant particles, including EVs from non‐target cell types, especially haematopoietic cells, albumin, lipoproteins and other abundant plasma proteins. Immunoaffinity detection or capture (IAC) methods can be used to selectively analyse target EVs based on surface marker expression. IAC confers critical benefits to liquid biopsy applications due to (i) removal of signal for a marker of interest from alternate tissue sources (enhances specificity) and (ii) greater depletion of abundant contaminants that supress signal for the marker (enhances sensitivity).

Similar articles

References

    1. Abdelmohsen, K. , Herman A. B., Carr A. E., et al. 2023. “Survey of Organ‐Derived Small Extracellular Vesicles and Particles (sEVPs) to Identify Selective Protein Markers in Mouse Serum.” Journal of Extracellular Biology 2, no. 8: e106. - PMC - PubMed
    1. Abou Zeid, F. , Charrier H., Beseme O., et al. 2022. “Lim Domain Binding 3 (Ldb3) Identified as a Potential Marker of Cardiac Extracellular Vesicles.” International Journal of Molecular Sciences 23, no. 13: 7374–7388. - PMC - PubMed
    1. Adnan, S.‐S. , Benjamin G. T., and David R. W.. 2023. “Advances in Extracellular Vesicle Isolation Methods: A Path towards Cell‐type Specific EV Isolation.” Extracellular Vesicles and Circulating Nucleic Acids 4, no. 3: 447–460. - PMC - PubMed
    1. Agliardi, C. , Guerini F. R., Zanzottera M., et al. 2023. “Myelin Basic Protein in Oligodendrocyte‐Derived Extracellular Vesicles as a Diagnostic and Prognostic Biomarker in Multiple Sclerosis: A Pilot Study.” International Journal of Molecular Sciences 24, no. 1: 894–903. - PMC - PubMed
    1. Agliardi, C. , Guerini F. R., Zanzottera M., et al. 2024. “Increased Concentrations of P2×7R in Oligodendrocyte Derived Extracellular Vesicles of Multiple Sclerosis Patients.” Neurobiology of Disease 199: 106601. - PubMed

LinkOut - more resources